Translational Research Center in Lung Cancer Disparities (TRACER) Project 2
NCT ID: NCT05490251
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
95 participants
OBSERVATIONAL
2024-01-31
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Communication in African American Smokers
NCT04084561
Contingency Management to Promote Smoking Abstinence in Cancer Patients
NCT04605458
Innovations to Prevent Relapse Among Low-income African American Smokers
NCT03982576
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
NCT05805722
Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
NCT02905656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 18-75 years old
* Smoke at least 5 to 10 cigarettes per day
Exclusion Criteria
* Have a personal history of lung cancer
* Personal history of usage of illicit drug and alcohol abuse
* Enrollment in a smoking cessation treatment program during the past 6 months
* Current use of a nicotine replacement therapy
* Have any positive responses on the Mini International Neuropsychiatric Interview (MINI) screener
18 Years
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Winn, MD
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southern California
Los Angeles, California, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00116801
Identifier Type: OTHER
Identifier Source: secondary_id
HM20022956
Identifier Type: OTHER
Identifier Source: secondary_id
MCC-21-18891
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.